{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:00:26Z","timestamp":1769547626063,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.heliyon.2019.e01947","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T01:08:23Z","timestamp":1560301703000},"page":"e01947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Repurposing of terconazole as an anti Trypanosoma cruzi agent"],"prefix":"10.1016","volume":"5","author":[{"given":"Chantal","family":"Reigada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melisa","family":"Say\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Valera-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana R.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2019.e01947_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1550-7408.1982.tb04024.x","article-title":"Adhesion and interiorization of Trypanosoma cruzi in mammalian cells","volume":"29","author":"Andrews","year":"1982","journal-title":"J.\u00a0Protozool."},{"key":"10.1016\/j.heliyon.2019.e01947_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpddr.2016.12.004","article-title":"In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: a comparison with Trypanosoma cruzi","volume":"7","author":"Botero","year":"2017","journal-title":"Int. J. Parasitol Drugs Drug Resist."},{"key":"10.1016\/j.heliyon.2019.e01947_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1017\/S143192760505035X","article-title":"Effects of inhibitors of Delta24(25)-sterol methyl transferase on the ultrastructure of epimastigotes of Trypanosoma cruzi","volume":"11","author":"Braga","year":"2005","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.heliyon.2019.e01947_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-0-387-77570-8_6","article-title":"Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections","volume":"625","author":"Buckner","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2019.e01947_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova Tripanosomiaze Humana: estudos sobre amorfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de uma nova entidade m\u00f3rbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.heliyon.2019.e01947_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000651","article-title":"Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole","volume":"4","author":"Chen","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2019.e01947_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0166-6851(81)90047-5","article-title":"Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruzi","volume":"3","author":"Docampo","year":"1981","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.heliyon.2019.e01947_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.heliyon.2019.e01947_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02098-16","article-title":"Antitrypanosomal activity of sterol 14alpha-demethylase (CYP51) inhibitors VNI and VFV in the Swiss mouse models of Chagas disease induced by the trypanosoma cruzi Y strain","volume":"61","author":"Guedes-da-Silva","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2019.e01947_bib10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/AAC.02287-15","article-title":"Clinical candidate VT-1161's antiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from trypanosoma cruzi","volume":"60","author":"Hoekstra","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2019.e01947_bib11","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1017\/S0031182018000562","article-title":"CYP51 as drug targets for fungi and protozoan parasites: past, present and future","volume":"145","author":"Lepesheva","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.heliyon.2019.e01947_bib12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/infdis\/jiv228","article-title":"VFV as a new effective CYP51 structure-derived drug candidate for Chagas disease and visceral leishmaniasis","volume":"212","author":"Lepesheva","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.heliyon.2019.e01947_bib13","doi-asserted-by":"crossref","first-page":"960","DOI":"10.4269\/ajtmh.1983.32.960","article-title":"Ketoconazole protects against infection with Trypanosoma cruzi in a murine model","volume":"32","author":"McCabe","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2019.e01947_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4269\/ajtmh.1986.35.280","article-title":"In vitro and in vivo effects of itraconazole against Trypanosoma cruzi","volume":"35","author":"McCabe","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2019.e01947_bib15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2019.e01947_bib16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/S0074-02762010000700014","article-title":"Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease","volume":"105","author":"Moreno","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.heliyon.2019.e01947_bib17","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.heliyon.2019.e01947_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"Perez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2019.e01947_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005472","article-title":"Trypanocidal effect of isotretinoin through the inhibition of polyamine and amino acid transporters in trypanosoma cruzi","volume":"11","author":"Reigada","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2019.e01947_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2019.e01947_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.heliyon.2019.e01947_bib22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000239458","article-title":"Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies","volume":"42","author":"Urbina","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1016\/j.heliyon.2019.e01947_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000238215","article-title":"Terconazole - a new broad-spectrum antifungal","volume":"29","author":"Van Cutsem","year":"1983","journal-title":"Chemotherapy"},{"key":"10.1016\/j.heliyon.2019.e01947_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/infdis\/jit042","article-title":"VNI cures acute and chronic experimental Chagas disease","volume":"208","author":"Villalta","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.heliyon.2019.e01947_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844019312861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844019312861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T01:02:40Z","timestamp":1716253360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844019312861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2405844019312861"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01947","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of terconazole as an anti Trypanosoma cruzi agent","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01947"}}